Western blot (n = 20) and immunohistochemistry (n = 92) in breast cancer patients indicated an inverse relationship between SVCT2 protein levels in tumor tissue and hormone receptor status, with low SVCT2 levels in normal tissue (69), again without ascorbate measurements. The gene discussed is SLC23A2; the disease is breast cancer.